Corporate Landscape of the Market: Recent Developments In May 2026, Novo Nordisk declared that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) implemented the marketing commercialization of Wegovy 7.2 mg, along with once-weekly injectable semaglutide 7.2 mg, in a single-dose pen for people living with obesity
Suddenly, its like I was Cinderella, back in the cellar with the mice
Most healthcare providersand most patientsreasonably decide that stopping before conception is the more conservative, prudent approach until we have better information
Bile acids are mild laxatives they pull water into the gut and speed up bowel motility
The amount of weight loss you may go through while taking Semaglutide GLP-1 can depend on various factors such as your individual metabolism, diet, exercise habits, and other health conditions